Envision Healthcare Corp. and its subsidiaries won dismissal of a False Claims Act suit alleging that they engaged in a scheme to submit claims to Medicare and TRICARE for anesthesia services that were tainted by kickbacks.

The Health Resources and Services Administration sent letters to several hospitals that participate in a federal drug discount program earlier this month, asking the hospitals to provide detailed information about how they comply with the program’s requirements.

HHS, DOL Formalize Anti-Child Labor Exploitation Partnership

A House committee advanced a Republican bill banning certain methods for measuring the effectiveness of prescription drugs, a move backed by major disability rights groups but opposed by the pharmaceutical industry’s biggest critics.

Another “maximum strength” pain relief deception suit has advanced, as a federal judge said Target Corp. must face a proposed class of consumers who say they were misled by the labels of its Up & Up lidocaine patches.

AbbVie Inc. and Merz Holding Gmbh & Co. affiliates received final approval for a $54.4 million settlement of a lawsuit that claimed the pharmaceutical companies conspired to block generic competition for the Alzheimer’s drug Namenda.